Oligorecurrent Prostate Cancer clinical trials

Explore recruiting oligorecurrent prostate cancer clinical trials.

Recruiting oligorecurrent prostate cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Oligorecurrent Prostate Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Stereotactic body radiotherapy with or without Darolutamide for OligoRecurrent prostate cancer: a randomized phase II trial (DART).

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Metastasis-directed therapy for oligorecurrent prostate cancer : A randomized phase III trial.

Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

Oligorecurrent Prostate Cancer trials by city

Oligorecurrent Prostate Cancer in Toronto Oligorecurrent Prostate Cancer in Vancouver Oligorecurrent Prostate Cancer in Montreal Oligorecurrent Prostate Cancer in Calgary Oligorecurrent Prostate Cancer in Edmonton Oligorecurrent Prostate Cancer in Ottawa Oligorecurrent Prostate Cancer in Winnipeg Oligorecurrent Prostate Cancer in Quebec City Oligorecurrent Prostate Cancer in Hamilton Oligorecurrent Prostate Cancer in Kitchener Oligorecurrent Prostate Cancer in London Oligorecurrent Prostate Cancer in Halifax Oligorecurrent Prostate Cancer in New York Oligorecurrent Prostate Cancer in Los Angeles Oligorecurrent Prostate Cancer in Chicago Oligorecurrent Prostate Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease